Total Valuation
Elevance Health has a market cap or net worth of $93.19B. The enterprise value is $115.48B.
Market Cap$93.19B
Enterprise Value$115.48B
Share Statistics
Elevance Health has 216,055,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding216,055,900
Owned by Insiders0.17%
Owned by Institutions2.01%
Financial Efficiency
Elevance Health’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 6.65%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)6.65%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee2.06M
Profits Per Employee58.59K
Employee Count96,615
Asset Turnover1.64
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Elevance Health is 18.4. Elevance Health’s PEG ratio is -5.70.
PE Ratio18.4
PS Ratio0.39
PB Ratio1.77
Price to FCF24.50
Price to Operating Cash Flow12.36
PEG Ratio-5.70
Income Statement
In the last 12 months, Elevance Health had revenue of 199.13B and earned 5.66B in profits. Earnings per share was 25.18.
Revenue199.13B
Gross Profit50.90B
Operating Income8.11B
Pretax Income6.71B
Net Income5.66B
EBITDA9.66B
Earnings Per Share (EPS)25.18
Cash Flow
In the last 12 months, operating cash flow was 7.60B and capital expenditures -1.08B, giving a free cash flow of 6.51B billion.
Operating Cash Flow7.60B
Free Cash Flow6.51B
Free Cash Flow per Share30.15
Dividends & Yields
Elevance Health pays an annual dividend of $1.72, resulting in a dividend yield of 1.59%
Dividend Per Share$1.72
Dividend Yield1.59%
Payout Ratio29.29%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.27
52-Week Price Change28.50%
50-Day Moving Average409.09
200-Day Moving Average369.66
Relative Strength Index (RSI)58.22
Average Volume (3m)494.00
Important Dates
Elevance Health upcoming earnings date is Jan 27, 2027, Before Open (Confirmed).
Last Earnings DateOct 21, 2026
Next Earnings DateJan 27, 2027
Ex-Dividend Date―
Financial Position
Elevance Health as a current ratio of 1.24, with Debt / Equity ratio of 68.84%
Current Ratio1.24
Quick Ratio1.24
Debt to Market Cap0.42
Net Debt to EBITDA2.46
Interest Coverage Ratio5.79
Taxes
In the past 12 months, Elevance Health has paid 1.05B in taxes.
Income Tax1.05B
Effective Tax Rate0.16
Enterprise Valuation
Elevance Health EV to EBITDA ratio is 10.51, with an EV/FCF ratio of 31.98.
EV to Sales0.51
EV to EBITDA10.51
EV to Free Cash Flow31.98
EV to Operating Cash Flow23.66
Balance Sheet
Elevance Health has $37.85B in cash and marketable securities with $30.76B in debt, giving a net cash position of $7.09B billion.
Cash & Marketable Securities$37.85B
Total Debt$30.76B
Net Cash$7.09B
Net Cash Per Share$32.81
Tangible Book Value Per Share$20.21
Margins
Gross margin is 36.55%, with operating margin of 4.07%, and net profit margin of 2.84%.
Gross Margin36.55%
Operating Margin4.07%
Pretax Margin3.37%
Net Profit Margin2.84%
EBITDA Margin4.85%
EBIT Margin4.07%
Analyst Forecast
The average price target for Elevance Health is $477.38, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$477.38
Price Target Upside20.50% Upside
Analyst ConsensusModerate Buy
Analyst Count14
Revenue Growth Forecast3.60%
EPS Growth Forecast-4.06%